Skip to main content
Skip to main navigation
Search
The University of British Columbia
UBC - A Place of Mind
The University of British Columbia
campus
UBC Search
UBC Search
UBC COVID-19 Research
Main menu
Home
Research Projects
All Research Projects
Medical Response
Social and Policy Response
COVID-19 Researchers
COVID-19 Researchers
Funding & Resources
Funding Opportunities
Initiatives & Websites
Ethics and Approvals for COVID-19 Research
Access to High-Performance Computing and Storage
Facilities
Publications
News
News
UBC Researchers in the News
For Media
For Media
This site has now been archived and content is not being updated.
You are here
Home
|
People
|
Josef Penninger
Josef Penninger
Canada 150 Chair in Functional Genetics, Professor
Department of Medical Genetics
Faculty of Medicine
COVID-19 Research Area(s)
Vaccines & Treatments
COVID-19 Projects (UBC Lead)
Evaluating a potential drug therapy for COVID-19
i-GlyCO: Immunoglobulin Glycosylation during COVID-19
Molecular and cellular therapies against COVID-19 using angiotensin-converting enzyme 2 (ACE2)
SARS‐CoV‐2 Study for Eased Restrictions in British Columbia – SAfER
COVID-19 Publications and Articles
Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2
Related News, Media and Articles
COVID-19: UBC researcher leads team that found potential Achilles heel
Here are five projects by companies tackling COVID-19 to watch in Canada
UBC professor uses knowledge of SARS to develop COVID-19 drug
We are finally unravelling the mystery of what causes severe COVID-19
Is a bradykinin storm brewing in COVID-19?
Three ways to make coronavirus drugs in a hurry
Mini-organs push along COVID-19 and other virus research
Lab-grown mini human organs may play key role in coronavirus drug development: Scientists
Injection of 'decoy proteins' could stop the coronavirus infecting cells within the body, scientists say
World leading geneticist and immunologist Josef Penninger on potential COVID-19 treatment